Profilo
Einar Pontén is currently the Head-Business Development at Lipum AB since 2016.
Previously, he worked as the Managing Director at Merck SeQuant AB and as the Head-Research & Development at Anolytech AB. Dr. Pontén holds a doctorate degree from Umea Universitet.
Posizioni attive di Einar Pontén
| Società | Posizione | Inizio |
|---|---|---|
| LIPUM AB | Corporate Officer/Principal | 01/12/2023 |
Precedenti posizioni note di Einar Pontén
| Società | Posizione | Fine |
|---|---|---|
Merck SeQuant AB
Merck SeQuant AB Medical SpecialtiesHealth Technology Provides liquid chromatography technology and other related products | Amministratore Delegato | 02/01/2011 |
Anolytech AB
Anolytech AB Wholesale DistributorsDistribution Services Provides disinfection of livestock farming and food production solutions | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Einar Pontén
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Merck SeQuant AB
Merck SeQuant AB Medical SpecialtiesHealth Technology Provides liquid chromatography technology and other related products | Health Technology |
Umea Universitet
Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anolytech AB
Anolytech AB Wholesale DistributorsDistribution Services Provides disinfection of livestock farming and food production solutions | Distribution Services |
Lipum AB
Lipum AB BiotechnologyHealth Technology Develops biological anti-inflammatory drugs | Health Technology |
















